Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th
Back

MedReleaf Announces R&D Collaboration and Investment in Cannabis Grow Lighting Firm Flora Fotonica

Sep 14, 2017 • 11:39 AM EDT
Canada Stocks (18).png
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

TEL-AVIV, Israel and TORONTO – Flora Fotonica Ltd., a developer of advanced grow light technologies for the Cannabis industry and MedReleaf Corp. (TSX: LEAF), Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, are pleased to announce the signing of a binding agreement to invest and collaborate on the research and development of specialized grow lighting systems for cannabis cultivation. Flora Fotonica will provide MedReleaf with exclusive access to its proprietary LED lighting technology and MedReleaf will dedicate licensed growing space, laboratories, and research personnel. Financial terms of the agreement are not disclosed.

“We have a deep connection to the world leading Israeli medical cannabis industry and a successful track record bringing their research and innovations to market on an industrial scale,” said Neil Closner, CEO of MedReleaf. “Our ability to iterate quickly and drive ongoing process improvements are a source of competitive advantage that allows us to increase capacity and lower production costs throughout our cultivation activities. In working with Flora Fotonica, we will continue to advance the global standard MedReleaf has set when it comes to product quality, yield, and crop optimization in the cannabis industry.”

Flora Fotonica has developed a proprietary lighting technology that is expected to enable significant increases to crops yield and active cannabinoids such as THC and CBD while substantially reducing energy consumption versus other LED lighting systems used in the industry today.

Flora Fotonica’s Co-Founder & CEO, Menachem Schwartz added: “MedReleaf is one of the global leaders in certified cannabis production and Flora Fotonica is a unique innovator in the indoor farming lighting systems arena. We believe the collaboration between our two companies will result in groundbreaking results in the cannabis market, both in terms of pricing as well as product quality.”

About Flora Fotonica Ltd.

An Israeli company established by technology and science veterans, Menachem Schwartz (CEO) and Gennadi Berinsky (CTO) in order to bring innovation and long-term solutions to “Better than Sun” lighting for indoor farming. The Company has developed proprietary technology producing significantly better results in crop yields and quality than conventional HPS and LED lighting with significantly reduced energy consumption.

About MedReleaf Corp.

MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world.  The first and only ICH-GMP and ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis.  Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.

For more information on MedReleaf, its products, research and how the Company is helping patients #livefree, please visit MedReleaf.com or follow @medreleaf.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Comments

Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link